biodesignalumni.com
Nothing to sneeze at: Lessons learned from the Acclarent experience.
J. Johnson & K. Wu Earlier this year, J&J announced its intention to acquire Acclarent, Inc. for $785 million, making it perhaps the biggest exit of the year in med devices and definitely c…